These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23775343)

  • 1. Widespread neuronal damage and cognitive dysfunction in spinocerebellar ataxia type 3.
    Lopes TM; D'Abreu A; França MC; Yasuda CL; Betting LE; Samara AB; Castellano G; Somazz JC; Balthazar ML; Lopes-Cendes I; Cendes F
    J Neurol; 2013 Sep; 260(9):2370-9. PubMed ID: 23775343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive deficits in Machado-Joseph disease correlate with hypoperfusion of visual system areas.
    Braga-Neto P; Dutra LA; Pedroso JL; Felício AC; Alessi H; Santos-Galduroz RF; Bertolucci PH; Castiglioni ML; Bressan RA; de Garrido GE; Barsottini OG; Jackowski A
    Cerebellum; 2012 Dec; 11(4):1037-44. PubMed ID: 22307858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance spectroscopy of the cerebellum in patients with spinocerebellar ataxia type 3/Machado-Joseph disease.
    Lei L; Liao Y; Liao W; Zhou J; Yuan Y; Wang J; Jiang H; Shen L; Tang B
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):511-9. PubMed ID: 21743142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain structural abnormalities in the preclinical stage of Machado-Joseph disease/spinocerebellar ataxia type 3 (MJD/SCA3): evaluation by MRI morphometry, diffusion tensor imaging and neurite orientation dispersion and density imaging.
    Li M; Chen X; Xu HL; Huang Z; Chen N; Tu Y; Gan S; Hu J
    J Neurol; 2022 Jun; 269(6):2989-2998. PubMed ID: 34783886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebellar cognitive affective syndrome in Machado Joseph disease: core clinical features.
    Braga-Neto P; Pedroso JL; Alessi H; Dutra LA; Felício AC; Minett T; Weisman P; Santos-Galduroz RF; Bertolucci PH; Gabbai AA; Barsottini OG
    Cerebellum; 2012 Jun; 11(2):549-56. PubMed ID: 21975858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene-Related Cerebellar Neurodegeneration in SCA3/MJD: A Case-Controlled Imaging-Genetic Study.
    Peng H; Liang X; Long Z; Chen Z; Shi Y; Xia K; Meng L; Tang B; Qiu R; Jiang H
    Front Neurol; 2019; 10():1025. PubMed ID: 31616370
    [No Abstract]   [Full Text] [Related]  

  • 7. Cerebral cortex involvement in Machado-Joseph disease.
    de Rezende TJ; D'Abreu A; Guimarães RP; Lopes TM; Lopes-Cendes I; Cendes F; Castellano G; França MC
    Eur J Neurol; 2015 Feb; 22(2):277-83, e23-4. PubMed ID: 25251537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multimodal evaluation of microstructural white matter damage in spinocerebellar ataxia type 3.
    Guimarães RP; D'Abreu A; Yasuda CL; França MC; Silva BH; Cappabianco FA; Bergo FP; Lopes-Cendes IT; Cendes F
    Mov Disord; 2013 Jul; 28(8):1125-32. PubMed ID: 23553599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Executive dysfunction in patients with spinocerebellar ataxia type 3.
    Tamura I; Takei A; Hamada S; Soma H; Nonaka M; Homma S; Moriwaka F
    J Neurol; 2018 Jul; 265(7):1563-1572. PubMed ID: 29725839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White matter damage is related to ataxia severity in SCA3.
    Kang JS; Klein JC; Baudrexel S; Deichmann R; Nolte D; Hilker R
    J Neurol; 2014 Feb; 261(2):291-9. PubMed ID: 24272589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CAG repeat length does not associate with the rate of cerebellar degeneration in spinocerebellar ataxia type 3.
    Huang SR; Wu YT; Jao CW; Soong BW; Lirng JF; Wu HM; Wang PS
    Neuroimage Clin; 2017; 13():97-105. PubMed ID: 27942452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The correlation between magnetic resonance imaging features of the brainstem and cerebellum and clinical features of spinocerebellar ataxia 3/Machado-Joseph disease.
    Liang X; Jiang H; Chen C; Zhou G; Wang J; Zhang S; Lei L; Wang X; Tang B
    Neurol India; 2009; 57(5):578-83. PubMed ID: 19934555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairments in Machado-Joseph disease.
    Kawai Y; Takeda A; Abe Y; Washimi Y; Tanaka F; Sobue G
    Arch Neurol; 2004 Nov; 61(11):1757-60. PubMed ID: 15534186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffuse alterations in grey and white matter associated with cognitive impairment in Shwachman-Diamond syndrome: evidence from a multimodal approach.
    Perobelli S; Alessandrini F; Zoccatelli G; Nicolis E; Beltramello A; Assael BM; Cipolli M
    Neuroimage Clin; 2015; 7():721-31. PubMed ID: 25844324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural signature of SCA3: From presymptomatic to late disease stages.
    Rezende TJR; de Paiva JLR; Martinez ARM; Lopes-Cendes I; Pedroso JL; Barsottini OGP; Cendes F; França MC
    Ann Neurol; 2018 Sep; 84(3):401-408. PubMed ID: 30014526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebellar morphometric and spectroscopic biomarkers for Machado-Joseph Disease.
    Miranda CO; Nobre RJ; Paiva VH; Duarte JV; Castelhano J; Petrella LI; Sereno J; Santana M; Afonso S; Januário C; Castelo-Branco M; de Almeida LP
    Acta Neuropathol Commun; 2022 Mar; 10(1):37. PubMed ID: 35305685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body mass index is inversely correlated with the expanded CAG repeat length in SCA3/MJD patients.
    Saute JA; Silva AC; Souza GN; Russo AD; Donis KC; Vedolin L; Saraiva-Pereira ML; Portela LV; Jardim LB
    Cerebellum; 2012 Sep; 11(3):771-4. PubMed ID: 22090366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain single-photon emission computed tomography and magnetic resonance imaging in Machado-Joseph disease.
    Etchebehere EC; Cendes F; Lopes-Cendes I; Pereira JA; Lima MC; Sansana CR; Silva CA; Camargo MF; Santos AO; Ramos CD; Camargo EE
    Arch Neurol; 2001 Aug; 58(8):1257-63. PubMed ID: 11493166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD.
    Switonski PM; Szlachcic WJ; Krzyzosiak WJ; Figiel M
    Neurobiol Dis; 2015 Jan; 73():174-88. PubMed ID: 25301414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spin labeling artery method perfusion MRI study of SPG4 and SCA3/MJD.
    Xing W; Wang XY; Liao XX; Liao WH; Shen L
    Magn Reson Imaging; 2014 Dec; 32(10):1330-4. PubMed ID: 25172988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.